Resource Center
Resource Center
Unitaid and CHAI brought together more than 80 organizations from 28 countries for the Future of HIV Markets Forum, held in Nairobi, in June 2026. We've put together a report with the actions this group has committed to.
Read more
CHAI is pleased to release Lessons from a decade of progress: reigniting momentum for hepatitis C elimination, a new report marking ten years of CHAI-supported hepatitis C programs in Cambodia, India, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam. Since 2016, these programs have screened 25.4 million people, cured an estimated 473,000, and helped drive the cost of a complete cure down by over 88 percent.
Read more
CHAI and Renaissance Philanthropy have published a TPP that defines what an affordable, point-of-care blood lead screening test should deliver, to accelerate the development of tools that can close a major testing gap.
Read more
New agreements with DeepTek and Delft Imaging cut annual software costs by up to 65 percent.
Read more
This is the current list of sessions with CHAI participation at AIDS 2026, which will take place virtually and in-person in Rio de Janeiro, Brazil from July 26 to 31, 2026.
Read more
CHAI, the Agency Fund, and Endless Network have launched the AI Commons for Global Health to ensure AI tools work for health systems in low- and middle-income countries.
Read more
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60 per patient. Few global health markets have changed so dramatically....
Read more
Updated analysis from CHAI tracks the state of African vaccine manufacturing ambitions in 2026 Africa has long relied on other parts of the world for its vaccines, a vulnerability COVID-19 made impossible to ignore. That crisis galvanized African leaders and international partners to act, prompting the creation of the Partnerships for African Vaccine Manufacturing (PAVM)...
Read more
New CHAI data from 2025 into early 2026: HIV testing, treatment, and prevention have shown little recovery from global funding cuts. Read the June 2026 memo.
Read more
Regional vaccine manufacturing in Southeast Asia has made significant progress but market risks remain. New CHAI and RVMC research maps these risks and sets out what needs to change.
Read more